TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod

Bulletin Express

04/07

TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.

The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.

Implementation hinges on two conditions: 1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM). 2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.

Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.

A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1148728314"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148728314\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148728314?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-07 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148728314","market":"us","top_or_hot":-1,"title":"TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod","media":"Bulletin Express","content":"<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.</p>\n<p>The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.</p>\n<p>Implementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.</p>\n<p>Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.</p>\n<p>A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRANSTHERA-B Board Endorses 2026 H-Share Award Scheme, Seeks Shareholder and HKEX Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-07 19:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.</p>\n<p>The programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.</p>\n<p>Implementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.</p>\n<p>Subject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.</p>\n<p>A circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02617","symbol_name":"药捷安康-B","start_time":0,"source_url":"","article_id":"1148728314","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148728314","pubTimestamp":1775562327,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02617":"药捷安康-B"},"translate_title":"Tranthera-B董事会批准2026年H股奖励计划，寻求股东和港交所认可","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02617":1},"content_text":"TransThera Sciences (Nanjing), Inc. (TRANSTHERA-B) has approved a proposal to establish a 2026 H Share Award Scheme aimed at incentivising employees, related-party participants and service providers.\nThe programme, cleared by the board on 7 April 2026, allows the Scheme Administrator to issue awards in the form of share options or share awards. Grants may be satisfied with treasury stock, newly issued H shares or existing H shares.\nImplementation hinges on two conditions:\n1. Shareholder approval via a special resolution at an upcoming extraordinary general meeting (EGM).\n2. Listing Committee approval for the listing and dealing of any new H shares issued under the scheme.\nSubject to EGM approval, the board also seeks authority for the Scheme Administrator to execute all documents and actions necessary to implement the plan.\nA circular outlining full details and the EGM notice will be released in due course. Until formal approvals are obtained, shareholders and potential investors are advised to exercise caution when trading the company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}